{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hyper-igm-syndrome-type-3","columns":[{"gene":"","key":"population-64c1d5d59929f24c38a8","label":"Immunodeficiency with hyper-igm, type 3","mondoId":"MONDO:0011735","onsetQualifier":null,"originColumnKey":"MONDO:0011735/OMIM:606843","originalViews":[{"key":"MONDO:0011735/OMIM:606843","label":"Immunodeficiency with hyper-igm, type 3","scopeLabel":"OMIM:606843","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["2d5b9c21d2fd8dfeaea006b694bfb705f52209363ea1ab243561324c4ae7c8f4","4bc1ae406ea522cd3abf584279e8570bf14b33dd00ea08d6a19683756f0f6eab","5787cde025482a8809ebfff7657fc983393fb6011d44af2db1916e571901f3b2","7061c19ec34067718a793d99be1f676eca127781726cc26303c1f196597d518e","b049f45c217990191b1438bfa66059b4153dacc18637324e750b61e5e0899ada","b8131555a9ba11727089439ca48ad511bad9bcaf6c979c548ad80fc4856abe12","be62836215c5293dfc7382635a67da21972b83af8bb0ebea46de2c086a0de6b2","d6f98d4a12ab2ff4c7925365daa99de54a6e86c916297ff5700ba66539f13d54","ed5200b55e0beb6a3a952763196d959797179998cca00e1be8da082a5ffc7af9","f4ed7ccdd07ccea167ce59b54a06cc21317828a3744be1295e750b236e51aa14"],"recordQualifiers":{},"scopeLabel":"OMIM:606843","sourceIds":["OMIM:606843"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-64c1d5d59929f24c38a8"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002849","HP:0002720","HP:0005479","HP:0004315","HP:0001875","HP:0002721","HP:0002959"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":10,"sourceGroups":{"omim":10}},"features":[{"hpoId":"HP:0002849","label":"Absence of lymph node germinal center","primary":true},{"hpoId":"HP:0002720","label":"Decreased circulating IgA concentration","primary":true},{"hpoId":"HP:0005479","label":"Decreased circulating IgE concentration","primary":true},{"hpoId":"HP:0004315","label":"Decreased circulating IgG concentration","primary":true},{"hpoId":"HP:0001875","label":"Decreased total neutrophil count","primary":true},{"hpoId":"HP:0002721","label":"Immunodeficiency","primary":true},{"hpoId":"HP:0002959","label":"Impaired Ig class switch recombination","primary":true},{"hpoId":"HP:0002847","label":"Impaired memory B cell generation","primary":false},{"hpoId":"HP:0003496","label":"Increased circulating IgM concentration","primary":false},{"hpoId":"HP:0002718","label":"Recurrent bacterial infections","primary":false}],"ledeHtml":"A form of Hyper IgM syndrome characterized by mutations of the CD40 gene. In this type, Immature B cells cannot receive signal 2 from helper T cells which is necessary to mature into mature B cells.","mondoId":"MONDO:0011735","node":{"canonicalSlug":"hyper-igm-syndrome-type-3","comparisons":[{"documentSha256":"7441566c6f0d70ab7081fdf79a58a2fe7fb56679aa2ac8fc26f6ecc21bd80e56","key":"legacy-hyper-igm-syndrome-type-3","kind":"legacy","label":"hyper-IgM syndrome type 3","memberIds":["MONDO:0011735"],"mondoId":"MONDO:0011735","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hyper-igm-syndrome-type-3.7441566c6f0d70ab7081fdf79a58a2fe7fb56679aa2ac8fc26f6ecc21bd80e56.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"hyper-IgM syndrome type 3","paragraphs":["A form of Hyper IgM syndrome characterized by mutations of the CD40 gene. In this type, Immature B cells cannot receive signal 2 from helper T cells which is necessary to mature into mature B cells."],"scope":"exact","source":"MONDO","upstream":"Wikipedia:Hyper-IgM_syndrome_type_3","url":"https://monarchinitiative.org/MONDO:0011735"},"ownColumnKeys":["population-64c1d5d59929f24c38a8"],"publication":"published","relationships":[{"kind":"parent","label":"hyper-IgM syndrome","mondoId":"MONDO:0003947","slug":"hyper-igm"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Description attribution is outside exact node scope","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/10579"}],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"2d5b9c21d2fd8dfeaea006b694bfb705f52209363ea1ab243561324c4ae7c8f4","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:606843","disease_name":"Immunodeficiency with hyper-igm, type 3","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002720","is_excluded":false,"label":"Decreased circulating IgA concentration","onset_id":null,"reference":"OMIM:606843","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"4bc1ae406ea522cd3abf584279e8570bf14b33dd00ea08d6a19683756f0f6eab","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:606843","disease_name":"Immunodeficiency with hyper-igm, type 3","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0005479","is_excluded":false,"label":"Decreased circulating IgE concentration","onset_id":null,"reference":"OMIM:606843","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5787cde025482a8809ebfff7657fc983393fb6011d44af2db1916e571901f3b2","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:606843","disease_name":"Immunodeficiency with hyper-igm, type 3","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002721","is_excluded":false,"label":"Immunodeficiency","onset_id":null,"reference":"OMIM:606843","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7061c19ec34067718a793d99be1f676eca127781726cc26303c1f196597d518e","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:606843","disease_name":"Immunodeficiency with hyper-igm, type 3","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0004315","is_excluded":false,"label":"Decreased circulating IgG concentration","onset_id":null,"reference":"OMIM:606843","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"b049f45c217990191b1438bfa66059b4153dacc18637324e750b61e5e0899ada","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:606843","disease_name":"Immunodeficiency with hyper-igm, type 3","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002959","is_excluded":false,"label":"Impaired Ig class switch recombination","onset_id":null,"reference":"OMIM:606843","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"b8131555a9ba11727089439ca48ad511bad9bcaf6c979c548ad80fc4856abe12","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:606843","disease_name":"Immunodeficiency with hyper-igm, type 3","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002718","is_excluded":false,"label":"Recurrent bacterial infections","onset_id":null,"reference":"OMIM:606843","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"be62836215c5293dfc7382635a67da21972b83af8bb0ebea46de2c086a0de6b2","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:606843","disease_name":"Immunodeficiency with hyper-igm, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001875","is_excluded":false,"label":"Decreased total neutrophil count","onset_id":null,"reference":"OMIM:606843","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"d6f98d4a12ab2ff4c7925365daa99de54a6e86c916297ff5700ba66539f13d54","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:606843","disease_name":"Immunodeficiency with hyper-igm, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003496","is_excluded":false,"label":"Increased circulating IgM concentration","onset_id":null,"reference":"OMIM:606843","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ed5200b55e0beb6a3a952763196d959797179998cca00e1be8da082a5ffc7af9","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:606843","disease_name":"Immunodeficiency with hyper-igm, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002849","is_excluded":false,"label":"Absence of lymph node germinal center","onset_id":null,"reference":"OMIM:606843","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f4ed7ccdd07ccea167ce59b54a06cc21317828a3744be1295e750b236e51aa14","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:606843","disease_name":"Immunodeficiency with hyper-igm, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002847","is_excluded":false,"label":"Impaired memory B cell generation","onset_id":null,"reference":"OMIM:606843","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011735\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Wikipedia:Hyper-IgM_syndrome_type_3</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A form of Hyper IgM syndrome characterized by mutations of the CD40 gene. In this type, Immature B cells cannot receive signal 2 from helper T cells which is necessary to mature into mature B cells.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011735\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"hyper-igm-syndrome-type-3","sourceDocuments":[{"name":"MONDO: hyper-IgM syndrome type 3","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011735"}],"sourceNote":"","synonyms":["CD40 hyper-IgM syndrome","HIGM3","hyper IgM syndrome 3","hyper-IgM syndrome caused by mutation in CD40","hyper-IgM syndrome due to CD40 deficiency","immunodeficiency with hyper IgM type 3","immunodeficiency with hyper-IgM type 3","immunodeficiency with hyper-IgM, type 3"],"takeawayHtml":"","title":"hyper-IgM syndrome type 3"},"schemaVersion":1}
